Migraine Clinical Trial
Official title:
Temporal Synthesis of Vestibular and Extra-Vestibular Sensory Signals
Verified date | March 2023 |
Source | Massachusetts Eye and Ear Infirmary |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Multiple sensory cues are typically generated by discrete events, and while they do not reach the cerebrum simultaneously, the brain can bind them temporally if they are interpreted as corresponding to a single event. The temporal binding of vestibular and non-vestibular sensory cues is poorly understood and has not been studied in detail, despite the fact that the vestibular system operates in an inherently multimodal environment. In this study, the researchers are investigating the physiology and pathophysiology of vestibular temporal binding by studying normal subjects, patients with peripheral and central vestibular dysfunction, and patients with vestibular and cochlear signals provided by prosthetic implants in the inner ear.
Status | Enrolling by invitation |
Enrollment | 472 |
Est. completion date | December 31, 2023 |
Est. primary completion date | December 31, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 8 Years to 80 Years |
Eligibility | Inclusion Criteria: Normal subjects - normal vestibular-oculomotor exams - normal low-frequency standard rotational testing - normal hearing Migraine - meets International Headache Society (IHS) criteria for migraine with or without aura - tested more than 2 weeks after most recent migraine headache Vestibular Migraine - meets Barany Society criteria for vestibular migraine, which includes: - episodic vestibular symptoms that occur with headaches that meet the IHS criteria for migraine - tested more than 2 weeks after most recent migraine headache or vestibular episode Vestibular Schwannoma - existence of unilateral vestibular schwannoma (pre & post clinical intervention e.g. surgical resection) - must plan to have clinical intervention such as sub-occipital surgical approach with complete sectioning of the vestibular nerve - rotational testing to assess pre-surgical vestibular function - audiogram - brain MRI consistent with vestibular schwannoma - audiography in each ear Vestibular (VI) and Cochlear (CI) Implant subjects - scheduled for CI surgery because of deafness - minimum 5 year history of documented absence of auditory and vestibular function, based on review of their audiograms and vestibular tests - specific vestibular criteria: peak ice water caloric response of less than 3deg/s for each ear; yaw VOR time constant <3s and gain <0.25; and reduced head impulse gain (<0.25) for all canal planes - specific audiographic criteria: 80dB or greater sensorineural hearing loss in both ears Exclusion Criteria: Normal subjects - history of otologic or neurologic disease - on vestibular suppressant medication (benzodiazepine, antihistamine, anticholinergic) - pregnant or recently (<6mos) pregnant Migraine - history of vestibular symptoms (other than motion sickness) - evidence of other neurologic or otologic dysfunction - on migraine prophylactic medications - on vestibular suppressant medication (benzodiazepine, antihistamine, anticholinergic) Vestibular Migraine (VM) - other neurologic or otologic dysfunction as defined above except for central eye movement findings that are consistent with VM and therefore not exclusionary. - on migraine prophylactic medication - on vestibular suppressant medication (benzodiazepine, antihistamine, anticholinergic) Vestibular Schwannoma - other otologic disease (other than presbycusis) or any neurologic disease (other than migraine) - on vestibular suppressant medication (benzodiazepine, antihistamine, anticholinergic) |
Country | Name | City | State |
---|---|---|---|
United States | Massachusetts Eye and Ear Infirmary | Boston | Massachusetts |
Lead Sponsor | Collaborator |
---|---|
Massachusetts Eye and Ear Infirmary | National Institute on Deafness and Other Communication Disorders (NIDCD), Oregon Health and Science University, University of Geneva, Switzerland |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Changes in postural sway/balance | Measurements of postural sway during Romberg testing on floor and foam (including an extra 60s balance test during which subject stands on foam and shakes head left and right at 1hz frequency while fixating on a point a set distance away) pre & post temporal binding adaptation (TBW & PSS training). | baseline and post temporal binding adaptation (1 hour) | |
Primary | Change in rapid measure of gait | This measure is scored before and after PSS and TBW adaptation in UVD (unilateral vestibular dysfunction) patients. Gait is scored by performance on a task derived from the FGA (walking 40 feet while turning the head from side to side). It is scored on a 0 to 10 visual scale and provides a rapid assessment of vestibular function pre and post adaptation. | baseline and post temporal binding adaptation (1 hour) | |
Primary | Change in measure of inducible dizziness | Looking at the change between before and after PSS and TBW adaptation in UVD (unilateral vestibular dysfunction) patients. Inducible dizziness is the symptom severity provoked by a task derived from the FGA (walking 40 feet while turning the head from side to side). It is scored on a 0 to 10 visual scale and provides a rapid assessment of vestibular function pre and post adaptation. | baseline and post temporal binding adaptation (1 hour) | |
Primary | Change in Motion Sickness (MS) Susceptibility | The investigators will use a well-validated variant of the classic Coriolis task, a pseudo-Coriolis task where subjects view a strong yaw-axis OKN stimulus while the head is tilted passively in roll at 1.0 Hz (starting 5 s after the vection illusion begins). The investigators found empirically that 40 roll tilts of the head were adequate to induce a range of MS symptoms, from virtually none in people with minimal MS sensitivity to severe nausea in people with more prominent MS sensitivity. Subjects grade their MS symptoms before and after the pseudo-Coriolis task using a simple visual analog (0 to 10) scale. | baseline and post temporal binding adaptation (1 hour) | |
Primary | Change in Point of Subjective Simultaneity (PSS) | Pre and post chronic motion-modulated stimulation in CI/VI patients - the PSS will be measured during temporal binding testing | baseline and 1 hour post 8-hour VI-CI 'physiologic' stimulation |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05525611 -
Cabergoline as a Preventive Treatment for Chronic Migraine
|
N/A | |
Completed |
NCT06192173 -
Patent Foramen Ovale Closure in Migraine
|
||
Recruiting |
NCT03832998 -
Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine
|
Phase 3 | |
Not yet recruiting |
NCT06428838 -
Eptinezumab as an Adjunct to Standard of Care for Migraine in an Acute Emergency Context
|
Phase 3 | |
Completed |
NCT06304675 -
Manageable Environmental Factors in Migraine
|
||
Completed |
NCT04084314 -
Assessment of Prolonged Safety and tOLerability of in Migraine Patients in a Long-term OpeN-label Study
|
Phase 4 | |
Recruiting |
NCT05517200 -
Pilot Study for a Machine Learning Test for Migraine
|
||
Completed |
NCT04179474 -
Safety, Tolerability and Drug- Drug Interaction Study of Ubrogepant With Erenumab or Galcanezumab in Participants With Migraine
|
Phase 1 | |
Recruiting |
NCT04603976 -
Registry for Migraine - Clinical Core
|
Phase 4 | |
Completed |
NCT03597529 -
CHOCOlate MeLatonin for AdolescenT MigrainE
|
Phase 2 | |
Completed |
NCT04197349 -
Safety, Tolerability and Pharmacokinetics of ALD1910 in Healthy Men and Woman
|
Phase 1 | |
Recruiting |
NCT05891808 -
miR-155 Expression in Episodic and Chronic Migraine
|
||
Active, not recruiting |
NCT05064371 -
Long-Term Extension Study With Eptinezumab as Preventive Treatment in Participants With Migraine in Japan
|
Phase 3 | |
Suspended |
NCT04069572 -
Vibratory Stimulation for the Treatment of Chronic Pain
|
N/A | |
Not yet recruiting |
NCT04859374 -
Chronic Pain and Conditioned Pain Modulation After on Line-behavioral Approach
|
N/A | |
Not yet recruiting |
NCT03083860 -
Evaluation of Migraine Management Mobile App Combined With Electrophysiological Measurements for Identification of Migraine Attack Risk and Beneficial Preventive Actions.
|
N/A | |
Completed |
NCT02905227 -
A Study of the Pulmonary Safety and Pharmacokinetics of Zolmitriptan Inhalation Powder
|
Phase 1 | |
Enrolling by invitation |
NCT02532023 -
The Combined Effects of omega3 Fatty Acids and Curcumin Supplementation on Inflammatory and Endothelial Factors in Migraine Patients
|
Phase 4 | |
Completed |
NCT02108678 -
One-Day Intervention for Depression and Impairment in Migraine Patients
|
N/A | |
Completed |
NCT01741246 -
Neuroimaging Studies of Chronic Primary Headaches Using Positron Emission Tomography and Magnetic Resonance Imaging
|
N/A |